Biomeasure Inc. will abandon its Milford location for the proximity to hospitals and research institutions offered by Cambridge’s Kendall Square.

The firm, a subsidiary of French pharmaceutical company Ipsen, has leased 63,000 square feet of space at 650 East Kendall St. in Cambridge. The company is moving its U.S. research and development operations from 27 Maple St. in Milford.

Ipsen signed an 11-year lease in the 282,000-square-foot Class A property, owned by BioMed Realty Trust. The firm will occupy the entire second floor and a portion of the fourth floor, and plans to move-in around mid-2014.

"This move puts our research capabilities in the center of Kendall Square, one of the preeminent life science communities in the world, including prominent hospital centers, medical schools, biotech companies, and universities," Cynthia Sylvestre, Biomeasure president, said in a statement.

Jack Burns, Adam Subber, Dan Sullivan and Paul Delaney of Cresa Boston represented Biomeasure in the lease transaction. Landlord BioMed Realty Trust Inc. was represented by Steven Purpura and Eric Smith of Richards Barry Joyce & Partners.

For the third quarter of 2013, Class A office space in East Cambridge was 6.4 percent vacant, "still tight, and rents remain elevated," according to information from the Boston office of commercial real estate brokerage Cassidy Turley. Rental rates for top-notch office space rose nearly 10 percent in the last year, averaging $56.39 a square foot in the third quarter. Lab space in East Cambridge, however, was more than 13 percent vacant.